# Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer

> **NCT00003072** · PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 80 (estimated)

## Conditions studied

- Lung Cancer
- Neurotoxicity
- Ovarian Cancer

## Interventions

- **DRUG:** amifostine trihydrate
- **DRUG:** carboplatin
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00003072
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-05
- **Primary completion:** 1998-10
- **Final completion:** 1998-10
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2012-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003072, "Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*